Simon Geissler und Daniel Helman - Info zur Person

(1 - 5 von 5

)

Breakthrough RNA-Based Anti-Cancer Immunotherapy ...PR Newswire

www.prnewswire.com

— ... Simon Geissler and Daniel Helman of Merck. "CanceRNA will initially focus on two cancer types, acute myeloid leukemia, relevant for ...

Breakthrough RNA-based Anti-CancerImmunotherapy ...medtechalert.com

medtechalert.com

— ... Leukemia Institute in Spain; Evelien Smits of the University of Brussels; and Regine Shevach, Simon Geissler and Daniel Helman of Merck. › news

CancerRNA Seeks to Develop and Validate RNA-Based ...Applied Radiation Oncology

www.appliedradiationoncology.com

... Simon Geissler and Daniel Helman of Merck. "CanceRNA will initially focus on two cancer types, acute myeloid leukemia, relevant for pediatric cancer, and ...

Breakthrough RNA-Based Cancer Immunotherapy Being Developed ...jlm-biocity.org › BioInnovation

jlm-biocity.org

· ... Merck Resech Activities in Israel,; Simon Geissler, Director, Healthcare Business of Merck; Daniel Helman, Project Leader, Merck Serono.

Breakthrough RNA-Based Anti-Cancer Immunotherapy ...BioSpace

www.biospace.com

— ... Leukemia Institute in Spain; Evelien Smits of the University of Brussels; and Regine Shevach, Simon Geissler and Daniel Helman of Merck.

Alle Infos zum Namen "Simon Geissler"

Verwandte Suchanfragen zu Simon Geissler

Markus Weigandt
Julian Quodbach
Martina Schmidt

Peter Langguth
Hellen Windolf
Philipp Schwarzer

Wolfgang Mohr
Meike Harms
Katharina Anhalt

Person "Geissler" (4)
Vorname "Simon" (30003)
Name "Geissler" (1002)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z